[1] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.DOI:10.1016/S0140-6736(19)30427-1.
[2] Shin S, Jun DW, Saeed WK, et al. A narrative review of malnutrition in chronic liver disease[J].Ann Transl Med,2021,9(2):172.DOI:10.21037/atm-20-4868.
[3] Koulentaki M, Drygiannakis I, Mantaka A, et al. Nutritional assessment of greek liver cirrhosis patients: mini nutritional assessment predicts mortality[J].Healthcare (Basel),2022,10(5):859.DOI:10.3390/healthcare10050859.
[4] Bellanti F, Lo Buglio A, Quiete S, et al. Comparison of three nutritional screening tools with the new glim criteria for malnutrition and association with sarcopenia in hospitalized older patients[J].J Clin Med,2020,9(6):1898.DOI:10.3390/jcm9061898.
[5] Li Y, Yang F, Zhou H, et al. Clinical application of NRS-2002 in nutritional risk screening of tuberculosis inpatients[J].Ann Palliat Med,2021,10(5):5322-5328.DOI:10.21037/apm-21-610.
[6] 吴绍香. 肝硬化患者营养筛查评估工具的研究进展[J]. 医学理论与实践,2022,35(10):1654-1657.DOI:10.19381/j.issn.1001-7585.2022.10.011.
[7] Bischoff SC, Bernal W, Dasarathy S, et al. ESPEN Practical Guideline: clinical nutrition in liver disease[J].Nutr Hosp,2022,39(2):434-472.DOI:10.20960/nh.03856.
[8] 中华医学会肝病学分会,中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 临床肝胆病杂志,2019,35(6):1222-1230.DOI:10.3969/j.issn.1001-5256.2019.06.010.
[9] European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J].J Hepatol,2019,70(1):172-193.DOI:10.1016/j.jhep.2018.06.024.
[10] Mueller C, Compher C, Ellen DM. A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults[J].JPEN J Parenter Enteral Nutr,2011,35(1):16-24.DOI:10.1177/0148607110389335.
[11] 杨晓玲,张素梅. SGA、MNA和NRS2002评估失代偿期肝硬化患者营养状态应用价值分析[J]. 实用肝脏病杂志,2020,23(1):70-73.DOI:10.3969/j.issn.1672-5069.2020. 01.020.
[12] Georgiou A, Papatheodoridis GV, Alexopoulou A, et al. Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study[J].Br J Nutr,2019,122(12):1368-1376.DOI:10.1017/S0007114519002277.
[13] Wu Y, Zhu Y, Feng Y, et al. Royal free hospital-nutritional prioritizing tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with nutritional risk screening 2002[J].Br J Nutr,2020,124(12):1293-1302.DOI:10.1017/S0007114520002366.
[14] 吴英珂,李满,陈辰,等. GLIM标准下3种营养筛查工具对肝硬化患者的适用性分析[J]. 临床肝胆病杂志,2022,38(2):352-358.DOI:10.3969/j.issn.1001-5256.2022.02.019.
[15] 杨帆,张伦,朱佳妮,等. 3种营养评价工具在肝硬化病人中的应用研究[J]. 全科护理,2020,18(30):4196-4198.DOI:10.12104/j.issn.1674-4748.2020.30.040.
[16] 朱娅鸽,吴宇超,王娟,等. 两种营养不良风险筛查工具在原发性肝癌住院患者中的应用比较[J]. 医学综述,2021,27(8):1616-1620.DOI:10.3969/j.issn.1006-2084.2021.08.029.
[17] 蒋慧. 营养风险筛查2002、营养不良通用筛查工具和患者主观整体评估在住院肿瘤患者中的应用[J]. 河南医学研究,2020,29(2):226-228.DOI:10.3969/j.issn.1004- 437X.2020.02.012.
[18] 吉琳琳,侯栋梁,宋丽楠,等. 营养风险筛查2002、营养不良通用筛查工具和患者主观整体评估在住院肿瘤患者中应用和比较[J]. 营养学报,2017,39(3):242-246.DOI:10.3969/j.issn.0512-7955.2017.03.008.
[19] 刘家硕,朴哲,杨瑞丽,等. 三种营养风险筛查工具对老年脑卒中住院患者的筛查与比较[J]. 中国老年学杂志,2020,40(20):4286-4288.DOI:10.3969/j.issn.1005-9202.2020. 20.009.
[20] 王晓丝,岳建新,栗雪琪,等. 营养不良通用筛查工具对酒依赖住院患者营养不良风险的评估[J]. 实用临床医药杂志,2021,25(5):30-32,44.DOI:10.7619/jcmp.20200909.
[21] 石汉平,丛明华,陈伟. 再论营养不良的三级诊断[J/CD]. 中国医学前沿杂志(电子版),2020,12(1):前插1,1-7.DOI:10.12037/YXQY.2020.01-01.
[22] Casas Deza D, Betoré Glaria ME, Sanz-París A, et al. Mini nutritional assessment - short form is a useful malnutrition screening tool in patients with liver cirrhosis, using the global leadership initiative for malnutrition criteria as the gold standard[J].Nutr Clin Pract,2021,36(5):1003-1010.DOI:10.1002/ncp.10640.
[23] Dağ Z, Köseoğlu H, Kekilli M. The use of prealbumin as a predictor of malnutrition in cirrhotic patients and the effect of nutritional support in patients with low prealbumin levels[J].Turk J Med Sci,2020,50(2):398-404.DOI:10.3906/sag-1910-27.
[24] Xiang S, Tan J, Tan C, et al. Establishment and validation of a non-invasive diagnostic nomogram to identify spontaneous bacterial peritonitis in patients with decompensated cirrhosis[J].Front Med (Lausanne),2022,8:797363.DOI:10.3389/fmed.2021.797363.
[25] 余锐填,关佩玲. 血清前白蛋白联合终末期肝病模型评分在失代偿期肝硬化患者临床预后评价中的意义[J]. 中西医结合肝病杂志,2020,30(6):498-501.DOI:10.3969/j.issn. 1005-0264.2020.06.002.
[26] 殷悦,祁兴顺,杨永平. 肝硬化患者营养状态的评估及管理[J]. 解放军医学杂志,2023,48(1):13-17.DOI:10.11855/j.issn.0577-7402.2023.01.0013.
[27] Lai JC, Tandon P, Bernal W, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases[J].Hepatology,2021,74(3):1611-1644.DOI:10.1002/hep.32049.
[28] 侯维,孟庆华. 肝硬化患者肌肉减少症的临床特点与发病机制研究进展[J]. 中西医结合肝病杂志,2021,31(5):385-390.DOI:10.3969/j.issn.1005-0264.2021.05.001.
[29] 余佳军. 骨骼肌营养不良在肝硬化患者临床预后评估中的作用研究[D].上海:中国人民解放军海军军医大学,2020.
[30] 王然,张永国,李谦谦,等.第三腰椎腰大肌面积指数对肝硬化患者营养状态及预后评估价值[J].临床军医杂志,2022,50(7):729-732.DOI:10.16680/j.1671-3826.2022.07.18.
[31] 张佩彦. 肝硬化患者营养评估及合并肌少症的相关研究[D].唐山:华北理工大学,2022.
[32] Moctezuma-Velazquez C, Ebadi M, Bhanji RA, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis[J].Clin Nutr,2019,38(6):2696-2703.DOI:10.1016/j.clnu.2018.11.024.
[33] 黄颖,余小平,陈怡,等. 失代偿期肝硬化患者营养不良诊断模型的探讨[J]. 四川医学,2023,44(2):117-123.DOI:10.16252/j.cnki.issn1004-0501-2023.02.002.
[34] 陈淦,刘茜,余珍,等. 肝硬化患者握力与营养风险相关性研究[J]. 当代护士(中旬刊),2021,28(4):92-94.DOI:10.19792/j.cnki.1006-6411.2021.11.032.
[35] Nishikawa H, Yoh K, Enomoto H, et al. Predictors for grip strength loss in patients with chronic liver diseases[J].In Vivo,2021,35(1):363-371.DOI:10.21873/invivo.12267.
[36] López-Bueno R, Andersen LL, Calatayud J, et al. Associations of handgrip strength with all-cause and cancer mortality in older adults: a prospective cohort study in 28 countries[J].Age Ageing,2022,51(5):afac117.DOI:10.1093/ageing/afac117.
[37] Zhuang CL, Zhang FM, Li W, et al. Associations of low handgrip strength with cancer mortality: a multicentre observational study[J].J Cachexia Sarcopenia Muscle,2020,11(6):1476-1486.DOI:10.1002/jcsm.12614.
[38] 李海燕,张瑞,邵盼,等. 不同营养评价方法与肝硬化腹水患者肝功能分级关系研究[J]. 海军医学杂志,2020,41(3):308-311.DOI:10.3969/j.issn.1009-0754.2020.03.019.
[39] 何玉梅,伍丽萍,王治铭,等. 肝硬化营养支持的研究进展[J]. 临床肝胆病杂志,2022,38(12):2846-2849.DOI:10.3969/j.issn.1001-5256.2022.12.031.
|